Calibration verification/linearity test kits, 9/16

September 2016—LGC Maine Standards released its Validate Tumor Markers and Validate Whole Blood Glucose calibration verification/linearity test kits. Validate Tumor Markers evaluate carcinoembryonic antigen and cancer antigens 15-3, 19-9, and 125 in a human serum-based matrix. Validate Whole Blood Glucose evaluates glucose in human whole blood on blood glucose meter systems used in hospital point-of-care settings.

Each test kit is prepared using the CLSI recommended “equal delta” method for linearity testing and is liquid, ready to use.

LGC Maine Standards, 800-377-9684